Prolonged lipopolysaccharide‐induced illness elevates glucagon‐like peptide‐1 and suppresses peptide YY: A human‐randomized cross‐over trial-Reference-Cited by-同舟云学术

Prolonged lipopolysaccharide‐induced illness elevates glucagon‐like peptide‐1 and suppresses peptide YY: A human‐randomized cross‐over trial

Published:2022-09 Issue:18 Volume:10 Page:
ISSN:2051-817X
Container-title:Physiological Reports
language:en
Short-container-title:Physiological Reports

Author:

Brodersen Katrine¹²³^ORCID,Mose Maike²,Ramer Mikkelsen Ulla⁴,Jørgensen Jens Otto Lunde²⁵^ORCID,Festersen Nielsen Michael¹,Møller Niels²,Wegeberg Anne‐Marie⁶,Brock Christina⁶⁷,Hartmann Bolette⁸,Holst Jens Juul⁸,Rittig Nikolaj²³

Affiliation:

1. Department of Surgery Viborg Regional Hospital Viborg Denmark

2. Medical/Steno Aarhus Research Laboratory Aarhus University Hospital, Aarhus University Aarhus Denmark

3. Steno Diabetes Center Aarhus Aarhus University Hospital Aarhus Denmark

4. Arla Foods Ingredients Group P/S Viby Denmark

5. Department of Endocrinology and Internal Medicine Aarhus University Hospital Aarhus Denmark

6. Mech‐Sense, Department of Gastroenterology and Hepatology Aalborg University Hospital Aalborg Denmark

7. Steno Diabetes Center North Denmark Aalborg University Hospital Aalborg Denmark

8. Department of Biomedical Sciences and Novo Nordisk Foundation Center for Basic Metabolic Research University of Copenhagen København Denmark

Funder

Aarhus Universitet

Arla Food for Health

Augustinus Fonden

Novo Nordisk Foundation Center for Basic Metabolic Research

Publisher

Wiley

Subject

Physiology (medical),Physiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.14814/phy2.15462

Reference59 articles.

1. Efficacy and safety of stress ulcer prophylaxis in critically ill patients: a network meta-analysis of randomized trials

2. Inhibition of Food Intake in Obese Subjects by Peptide YY3–36

3. Whole Gut Transit Scintigraphy in The Clinical Evaluation of Patients With Upper and Lower Gastrointestinal Symptoms

4. Persistently Elevated Glucagon-Like Peptide-1 Levels among Critically Ill Surgical Patients after Sepsis and Development of Chronic Critical Illness and Dismal Long-Term Outcomes

5. Neuronal nitric oxide in the gut